Corient Private Wealth LP Invests $10.44 Million in Humana Inc. $HUM

Corient Private Wealth LP bought a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm bought 624,775 shares of the insurance provider's stock, valued at approximately $10,441,000. Corient Private Wealth LP owned approximately 0.52% of Humana as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Permanens Capital L.P. bought a new stake in Humana during the second quarter worth about $1,546,000. Bank of America Corp DE bought a new position in shares of Humana in the second quarter valued at approximately $279,490,000. Summit Street Capital Management LLC bought a new position in shares of Humana in the second quarter valued at approximately $36,325,000. Freestone Grove Partners LP acquired a new position in shares of Humana in the 2nd quarter worth approximately $20,413,000. Finally, Caisse de depot et placement du Quebec acquired a new position in shares of Humana in the 2nd quarter worth approximately $918,000. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on HUM shares. Morgan Stanley raised Humana from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $249.00 to $370.00 in a report on Tuesday, August 4th. Weiss Ratings raised Humana from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, August 14th. Mizuho increased their target price on Humana from $335.00 to $390.00 and gave the stock an "outperform" rating in a report on Monday, June 8th. HSBC lowered Humana to a "hold" rating in a research note on Thursday, July 30th. Finally, Sanford C. Bernstein reaffirmed an "outperform" rating and issued a $425.00 price target on shares of Humana in a report on Wednesday, June 3rd. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $403.91.

Humana Stock Performance

Shares of Humana stock opened at $386.92 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a 50 day simple moving average of $385.60 and a 200 day simple moving average of $288.47. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The firm has a market cap of $46.46 billion, a P/E ratio of 36.61, a P/E/G ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business's revenue for the quarter was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.27 EPS. Sell-side analysts predict that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source